Finnrick - Ensuring a Safer and More Transparent Supply Chain
LSPL

LSPL

Retatrutide

Finnrick tested 5 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from LSPL between 6 Nov 2025 and 23 Nov 2025. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).

Finnrick Rating™
Tentative Rating
LSPL
Retatrutide
Tested 5 Samples
Last test 23 Nov 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Retatrutide tests from LSPL

Samples are tested in commercial labs

Tests Count

5

Scores

AVG6.4MIN4.3MAX8.0

Last

23 Nov 2025

First

6 Nov 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityEndotoxinsBatch IDContainerTested AtSent By
23 Nov 2025View5.320mg16.800mg-16.0%99.80%n/a(no batch ID)No Label / Copper Crimp / Clear CapLab GPublic
23 Nov 2025View4.320mg35.200mg+76.0%99.90%n/a(no batch ID)No Label / Copper Crimp / Clear CapLab GPublic
17 Nov 2025View7.230mg30.600mg+2.0%98.20%n/aSEPT 4 2025No Label / Silver Crimp / White CapLab EPublic
17 Nov 2025View7.410mg10.200mg+2.0%98.39%
not detected
10132025/10mgNo Label / Silver Crimp / Clear Blue CapLab EPublic
6 Nov 2025View8.010mg9.790mg-2.1%99.95%n/a(no batch ID)No Label / Silver Crimp / Clear Blue CapLab EPublic